Prominent Patent Litigation Filed in Delaware: Advanced Accelerator Applications USA, Inc. et al. v. Lantheus Medical Imaging, Inc. et al.
Wilmington, Delaware – A significant patent infringement lawsuit has been filed in the District of Delaware, a jurisdiction renowned for its robust intellectual property litigation. Advanced Accelerator Applications USA, Inc. and Advanced Accelerator Applications S.A. (collectively referred to as “AAA”) have initiated legal proceedings against Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. (collectively referred to as “Lantheus”). The case, designated as 1:24-cv-00095, was officially published on August 14, 2025, at 23:47 Eastern Time, according to information from GovInfo.gov.
This legal action centers on allegations of patent infringement related to innovative technologies within the medical imaging sector. While the specific patents and the full scope of the alleged infringement are detailed within the court filings, the case signifies a high-stakes dispute between two notable entities in the field of medical diagnostics and radiopharmaceuticals.
Advanced Accelerator Applications USA, Inc., a subsidiary of Novartis, is a recognized leader in the development and commercialization of molecular nuclear medicine, particularly in the areas of targeted radioligand therapies and diagnostic imaging agents. Lantheus Medical Imaging, Inc. is also a prominent player, known for its portfolio of diagnostic imaging agents and radiopharmaceutical products used to aid physicians in diagnosing and treating medical conditions.
The filing of this lawsuit in the District of Delaware underscores the court’s established expertise in handling complex patent disputes. Parties often choose this venue due to its experienced judiciary, established procedural rules, and a track record of efficient case management in patent cases.
The nature of the allegations suggests a disagreement over intellectual property rights and the alleged unauthorized use of patented technologies by Lantheus. The outcome of this litigation could have a notable impact on the competitive landscape and future innovation within the specialized field of medical imaging and radiopharmaceuticals.
As this case progresses through the legal system, further details are expected to emerge regarding the specific claims and defenses presented by both AAA and Lantheus. Parties involved in the medical technology sector, as well as those interested in intellectual property law, will be closely observing the developments in this important case.
24-095 – Advanced Accelerator Applications USA, Inc. et al v. Lantheus Medical Imaging, Inc. et al
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
govinfo.gov District CourtDistrict of Delaware published ’24-095 – Advanced Accelerator Applications USA, Inc. et al v. Lantheus Medical Imaging, Inc. et al’ at 2025-08-14 23:47. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.